Business

Magnolia Medical Welcomes Sarah Huber as Senior Vice President, Sales

Magnolia Medical Technologies, Inc., the inventor of the Steripath® Initial Specimen Diversion Device® platform and the ISDD market to prevent false-positive sepsis test results, announced the appointment of Sarah Huber as Senior Vice President of Sales. Sarah will lead Magnolia Medical's U.S. sales organization, overseeing commercial strategy and execution to accelerate adoption of the Steripath® platform across hospitals and healthcare systems nationwide.

articlePulmonx CorporationFebruary 12, 20262/company/pulmonx-corp/news/magnolia-medical-welcomes-sarah-huber-as-senior-vice-president-sales
Magnolia Medical Welcomes Sarah Huber as Senior Vice President, Sales

About this update from Pulmonx Corporation

[{"type":"text","content":"Experienced MedTech Commercial Leader Brings More Than 20 Years of Sales Leadership to Drive Continued Growth","length":109,"tagName":"p"},{"type":"text","content":"SEATTLE, Feb. 12, 2026 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the inventor of the Steripath® Initial Specimen Diversion Device® platform and the ISDD market to prevent false-positive sepsis test results, announced the appointment of Sarah Huber as Senior Vice President of Sales. Sarah will lead Magnolia Medical's U.S. sales organization, overseeing commercial strategy and execution to accelerate adoption of the Steripath® platform across hospitals and healthcare systems nationwide.","length":509,"tagName":"p"},{"type":"image","alt":"Magnolia Medical Technologies, Inc. inventors of the initial specimen diversion technique (ISDT™) and the Steripath® Initial Specimen Diversion Device® (ISDD®) for blood culture collection and contamination prevention. (PRNewsfoto/Magnolia Medical Technologies)","displaySize":"","headline":null,"caption":"Magnolia Medical Technologies, Inc. inventors of the initial specimen diversion technique (ISDT™) and the Steripath® Initial Specimen Diversion Device® (ISDD®) for blood culture collection and contamination prevention. (PRNewsfoto/Magnolia Medical Technologies)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":89,"url":"https://media.zenfs.com/en/prnewswire.com/eb2958bb17cff81e7a9a4119f38dcf7c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.ejZMOxc0.CVFDoe7pbumA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/eb2958bb17cff81e7a9a4119f38dcf7c","width":400,"height":89},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/iZezB8b8SWsGWQtJHGXMCg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE0MjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/eb2958bb17cff81e7a9a4119f38dcf7c","width":400,"height":89}},"href":"https://mma.prnewswire.com/media/1002877/Magnolia_Medical_Technologies_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Huber is a seasoned sales and commercial executive with more than two decades of leadership experience in healthcare and medical device sales. She brings deep expertise in building and scaling high-performance sales organizations, expanding market presence, and succe...

More updates from Pulmonx Corporation

Sarah HuberMagnolia MedicalMedical Technologiesrevenue growthHuberSenior Vice PresidentSarah